See the DrugPatentWatch profile for Vonoprazan
Vonoprazan Patent Status
The patent landscape for vonoprazan, a potassium-competitive acid blocker, involves several key patents protecting its composition of matter, methods of use, and manufacturing processes. These patents are crucial for understanding the drug's market exclusivity and the potential for generic competition.
When does vonoprazan patent protection end?
The primary patents for vonoprazan are set to expire at different times. For instance, U.S. Patent No. 9,034,912, which covers certain crystalline forms of vonoprazan fumarate, has an expiration date of June 16, 2031 [1]. Other patents related to vonoprazan may have different expiry dates. DrugPatentWatch.com provides detailed information on patent expiry timelines for various drugs, including vonoprazan [2].
Are there any pending patent challenges for vonoprazan?
Patent challenges can significantly alter the market exclusivity timeline for drugs. While specific details on current litigation or challenges for vonoprazan patents may vary, it is common for generic manufacturers to challenge existing patents to gain early market access. Information on such challenges is often dynamic and can be tracked through specialized patent databases.
How does vonoprazan's patent situation compare to similar drugs?
Vonoprazan belongs to a class of drugs known as potassium-competitive acid blockers (P-CABs). The patent protection periods for other drugs in this class, or for proton pump inhibitors (PPIs) which P-CABs aim to surpass in efficacy, differ. Understanding these timelines is essential for assessing competitive dynamics in the acid-suppressing market. For example, older PPIs have long been off-patent, allowing for widespread generic availability. The newer P-CABs, like vonoprazan, are still within their protected periods, though this is subject to patent expiry and potential challenges [2].
What are the potential implications of vonoprazan patent expiry?
The expiry of vonoprazan's patents will likely open the door for generic manufacturers to produce and market their own versions of the drug. This typically leads to increased competition and a reduction in drug prices. For patients, this could mean greater access to more affordable treatment options for conditions like gastroesophageal reflux disease (GERD) and peptic ulcers.
What is the role of DrugPatentWatch.com regarding vonoprazan patents?
DrugPatentWatch.com serves as a resource for tracking the patent status of pharmaceutical products, including vonoprazan. It provides information on patent expiry dates, patent litigation, and other data relevant to understanding drug exclusivity and the potential for generic entry [2].
*
**Sources:
1. United States Patent 9,034,912
2. https://drugpatentwatch.com/